Edgar Tenorio

Dr. Tenorio has worked in the biotechnology/pharmaceutical sector for more than 17 years as a Research Scientist, Associate Director Preclinical Development, and most recently as a Nonclinical Pharmacology/Toxicology/Bioanalytical consultant. Dr. Tenorio has worked on developing biologics (peptides, proteins, and monoclonal antibodies) and small molecules in a variety of therapeutic areas (vaccines, inflammation, pain, autoimmune diseases, oncology, infectious diseases, Alzheimer’s, and Cystic Fibrosis).

For the last 8 years he has been responsible for taking lead therapeutic candidates from preclinical to first in man (Phase 1) and follow-up clinical trials (Phase 2 and 3). He has worked at Neurex, Elan, Pepgen and KaloBios. Dr. Tenorio holds a BS in biomedical science from Texas A&M University, a DVM from the National University of Mexico, and a Masters in Preventive Veterinary Medicine from the University of California, Davis. Dr. Tenorio was an NIH post-doctoral fellow in comparative pathology and immunology at the University of California, Davis.